As from May 29, 2020, NeuroVive Pharmaceutical AB will be listed under its new company name Abliva AB New company name: Abliva AB New short name: ABLI Unchanged ISIN code: SE0002575340 Unchanged Order book ID: 58531 For further information about this exchange notice, please contact iss@nasdaq.com or +46 8 405 7050 Nasdaq Stockholm AB